CommunicationRadConnectNCT05540444
RadConnect Communication Application
An observational study of Communication, run by Philips Clinical & Medical Affairs Global at 1 site in Netherlands.
Trial summary
The aim is to evaluate the impact of an innovative asynchronous communication application on the number of calls from technologists to radiologists. Even though it is paramount that radiologists be accessible and available to other healthcare workers in the enterprise, frequent interruptions have negative impact on… Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Communication
- What is being tested?
- RadConnect
- Type of treatment
- Medical device
- How many people
- 79 participants
- Where
- 1 siteNetherlands
- Study dates
- 29 Sep 2022to 13 Jul 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: Subjects are not patients, but radiologists, technologist, doctor assistants and physician assistants employeed by LUMC. That drive the radiological workflow and frequently raise and answer questions related to the image acquisition.
Who may be able to join
- Individuals that are employed by LUMC
- Individuals that are radiologists, radiology fellows, radiology residents, radiology technologists, doctor assistants, physician assistants or other support personnel in the Department of Radiology that raise managing image acquisition related questions.
- Individuals that consent to participating in the study.
- Individuals scheduled to work at locations at Sending Extensions, Receiving Extensions and Control Extensions.
Who cannot join
- Individuals not able to understand or not willing to sign the informed consent form.
- Individuals that indicate that they do no comprehend RadConnect and/or its intended use after two educational sessions.
- Individuals not able to not willing to comply with the intended use of RadConnect.
Trial locations and contacts
1 site in 1 country.
About this study
The aim is to evaluate the impact of an innovative asynchronous communication application on the number of calls from technologists to radiologists. Even though it is paramount that radiologists be accessible and available to other healthcare workers in the enterprise, frequent interruptions have negative impact on productivity and well-being. A novel communication app was developed that streamlines communication between technologists and radiologists: RadConnect.
- Conditions
- Communication
- Being tested
- RadConnect
- Keywords
- Radiologists, Radiology Technologists
- Medical subject headings
- Communication
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
RadConnectDevice
The study will be performed in a clinical setting at the department of radiology of LUMC, meaning that we aim to test the hypothesis that ("RadConnect") can reduce the number of phone calls from a select set of extension used by technologists (the "Sending Extensions") to another select set of extensions manned by radiologists ("Receiving Extensions").
What is being measured
The primary outcome is the main question the study is designed to answer.
Test the hypothesis that adoption of RadConnect leads to reduction of phone calls to radiologists.
- P1 = Mean number of calls per working day during regular working hours between Sending Extensions and Receiving Extensions in Before Phase
- P2 = Mean number of calls per working day during regular working hours between Sending Extensions and Receiving Extensions in After Phase
The primary endpoint will be obtained by testing the hypothesis that P1 > P2 using Wilcoxon's one-tailed test with significance level P < 0.05.
Measured: Numbers are continously measured during each shift of the subjects over a period of 40 consecutive working days during the before (phase 1) and 40 consecutive working days during the after phase (phase 2) of this study.
Secondary outcomes (3)
Compare experiences and attitudes of technicians and radiologists towards RadConnect versus phone calls.
- C1 = Mean number of calls per working day during regular working hours between Sending Extensions and Control Extensions in Before Phase
- C2 = Mean number of calls per working day during regular working hours between Sending Extensions and Control Extensions in After Phase
The first secondary endpoint will be obtained by testing the hypothesis that C1 ≠ C2 using Wilcoxon's two-tailed test with significance level P < 0.05.
Measured: Continously measured during each shift of the subjects over a period of 40 consecutive working days during the before (phase 1) and 40 consecutive working days during the after phase(phase 2) of this study.
Measure the characteristics of technician questions raised over phone and through RadConnect.
- R2 = Mean number of completed RadConnect consultations per working day during regular working hours between Sending Extensions and Receiving Extensions in After Phase
The second secondary endpoint will be obtained by testing the hypothesis that P1 ≠ P2 + R2 using Wilcoxon's two-tailed test with significance level P < 0.05.
Measured: Continously measured during each shift of the subjects over a period of 40 consecutive working days during the before phase (phase 1) and 40 consecutive working days during the after phase (phase 2) of this study.
Consolidated opinion usability and experience of RadConnect in itself and in comparison to alternative communication methods.
The third secondary endpoint will be obtained by aggregating survey responses. In the structured online survey, if more than half of the respondents indicate that they prefer communication over RadConnect to calling, it will be concluded that RadConnect is a viable alternative to calling. If more than half of radiologist respondents indicate that they believe RadConnect helps them avoid interruptions, it will be concluded that RadConnect is a viable alternative to calling that may help reduce radiologist interruptions. The opinions of study participants are captured as Likert scale response and averaged to obtain a consolidated opinion. The consolidated responses are visualized as histograms.
Measured: 1 hour, after completion of the after phase (phase 2 of this study)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Sep 2022
- Study start29 Sep 2022
- Primary completion13 Jul 2023
- Study completion13 Jul 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CommunicationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case crossover
- Time perspective
- Prospective
- Enrolment
- 79 participants (actual)
Sponsor and investigators
- Lead sponsor
- Philips Clinical & Medical Affairs Global
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Leiden University Medical Center
- Responsible party
- Sponsor
- Investigators
- Hildo Lamb, Prof. Dr., Principal investigator, Leiden University Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05540444
- Sponsor's protocol ID
- ICBE-S-000556
- Acronym
- RadConnect
- Status last verified
- Jul 2023
- First submitted
- 8 Sep 2022
- Last updated
- 21 Jul 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 21 Jul 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- RadConnect Communication Application
- ClinicalTrials.gov ID
- NCT05540444
- Acronym / sponsor ID
- RadConnect / ICBE-S-000556
- Conditions
- Communication
- Keywords
- Radiologists, Radiology Technologists
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 79 participants (actual)
- Lead sponsor
- Philips Clinical & Medical Affairs GlobalIndustry (pharma, biotech, devices)
- Collaborators
- Leiden University Medical Center
- Study start
- 29 Sep 2022 (actual)
- Primary completion
- 13 Jul 2023 (actual)
- Study completion
- 13 Jul 2023 (actual)
- First posted
- 14 Sep 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim is to evaluate the impact of an innovative asynchronous communication application on the number of calls from technologists to radiologists. Even though it is paramount that radiologists be accessible and available to other healthcare workers in the enterprise, frequent interruptions have negative impact on productivity and well-being. A novel communication app was developed that streamlines communication between technologists and radiologists: RadConnect.
Study design
- Observational model
- Case crossover
- Time perspective
- Prospective
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Subjects are not patients, but radiologists, technologist, doctor assistants and physician assistants employeed by LUMC. That drive the radiological workflow and frequently raise and answer questions related to the image acquisition.
Key inclusion criteria (4 listed)
- Individuals that are employed by LUMC
- Individuals that are radiologists, radiology fellows, radiology residents, radiology technologists, doctor assistants, physician assistants or other support personnel in the Department of Radiology that raise managing image acquisition related questions.
- Individuals that consent to participating in the study.
- Individuals scheduled to work at locations at Sending Extensions, Receiving Extensions and Control Extensions.
Key exclusion criteria (3 listed)
- Individuals not able to understand or not willing to sign the informed consent form.
- Individuals that indicate that they do no comprehend RadConnect and/or its intended use after two educational sessions.
- Individuals not able to not willing to comply with the intended use of RadConnect.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| RadConnectThe study will be performed in a clinical setting at the department of radiology of LUMC, meaning that we aim to test the hypothesis that ("RadConnect") can reduce the number of phone calls from a select set of extension used by technologists (the "Sending Extensions") to another select set of extensions manned by radiologists ("Receiving Extensions"). | Device | – |
Primary outcome
Test the hypothesis that adoption of RadConnect leads to reduction of phone calls to radiologists.
Time frame: Numbers are continously measured during each shift of the subjects over a period of 40 consecutive working days during the before (phase 1) and 40 consecutive working days during the after phase (phase 2) of this study.
* P1 = Mean number of calls per working day during regular working hours between Sending Extensions and Receiving Extensions in Before Phase * P2 = Mean number of calls per working day during regular working hours between Sending Extensions and Receiving Extensions in After Phase The primary endpoint will be obtained by testing the hypothesis that P1 > P2 using Wilcoxon's one-tailed test with significance level P < 0.05.
3 secondary outcomes
Compare experiences and attitudes of technicians and radiologists towards RadConnect versus phone calls.
Time frame: Continously measured during each shift of the subjects over a period of 40 consecutive working days during the before (phase 1) and 40 consecutive working days during the after phase(phase 2) of this study.
Measure the characteristics of technician questions raised over phone and through RadConnect.
Time frame: Continously measured during each shift of the subjects over a period of 40 consecutive working days during the before phase (phase 1) and 40 consecutive working days during the after phase (phase 2) of this study.
Consolidated opinion usability and experience of RadConnect in itself and in comparison to alternative communication methods.
Time frame: 1 hour, after completion of the after phase (phase 2 of this study)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Jul 2023.
- Individual participant dataSharing planned: No
Related trials for Communication
Recruiting
Feasibility and Preliminary Effects of a Therapeutic Approach Using Ultrasound Visual Biofeedback in Children With AFI: a Pilot Randomized Clinical Trial.
Childhood Apraxia of Speech, Speech Sound Disorders
Active, not recruiting
Keep Social Randomized Controlled Trial for Young Adults With Cancer
Cancer
Not yet recruiting
Examining the Impact of a Patient Communication Pathway in the Critical Care Setting on Patient Experience and Nursing Staff's Perceptions of Usability
Communication Barriers
Not yet recruiting
Single Session Support for Parents of Children With Neurodevelopmental Disabilities Struggling With Anxious Avoidance
Neurodevelopmental Disorders, Autism Spectrum Disorder (ASD)
Not yet recruiting
Evaluation of a Novel Quantum-Inspired Intervention (QII) for Children With Autism Spectrum Disorder: A Global Confirmatory Study
Autism Spectrum Disorder, Autism Spectrum Disorder (ASD
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Hildo Lamb, Prof. Dr. principal investigator
Leiden University Medical Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Communication, run by Philips Clinical & Medical Affairs Global at 1 site in Netherlands.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Test the hypothesis that adoption of RadConnect leads to reduction of phone calls to radiologists. (time frame: Numbers are continously measured during each shift of the subjects over a period of 40 consecutive working days during the before (phase 1) and 40 consecutive working days during the after phase (phase 2) of this study.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jul 2023; AzTrials last refreshed its copy on 28 Oct 2026.